Merrimack Pharmaceuticals, Inc.
Country
USA
Краткое название
Merrimack Pharmaceuticals, Inc.
Headquarters
One Kendall Square Suite B7201 Cambridge, MA 02139 United States
Members of the board
Robert J. Mulroy,
Anthony J. Sinskey,
William A. Sullivan,
William M. Mcclements,
Fazal R. Khan,
Gary L. Crocker,
Robert J. Mulroy,
Anthony J. Sinskey,
Sarah Elizabeth Nash,
Peter K. Sorger
Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Breast cancer, Intestine cancer
Ticker
MACK
Current owners
Robert Mulroy,
Anthony Sinskey,
Gary Crocker,
Sarah Nash,
Peter Sorger,
Gordon Fehr,
Michael Porter,
James Marks,
Barret Rollins,
Louis Weiner,
Michael Yaffe,
Douglas Lauffenburger,
James Dresser,
John Park,
Christopher Benz,
John Mendelsohn,
James Quigley
Assets
1.3100
Technology
Homogeneous antibodies, Devices, Technologies, Pharmaceuticals, Chemistry